TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 226 filers reported holding TG THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.78 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $360,373 | +27.6% | 23,961 | +0.4% | 0.02% | +15.8% |
| Q4 2022 | $282,370 | +107.6% | 23,869 | +3.8% | 0.02% | +111.1% |
| Q3 2022 | $136,000 | +24.8% | 22,986 | -10.6% | 0.01% | +50.0% |
| Q2 2022 | $109,000 | -42.0% | 25,715 | +30.1% | 0.01% | -40.0% |
| Q1 2022 | $188,000 | -37.3% | 19,772 | +25.2% | 0.01% | -44.4% |
| Q4 2021 | $300,000 | +35.1% | 15,787 | +136.4% | 0.02% | +50.0% |
| Q3 2021 | $222,000 | -64.6% | 6,679 | -58.8% | 0.01% | -64.7% |
| Q2 2021 | $628,000 | +76.4% | 16,196 | +119.5% | 0.03% | +70.0% |
| Q1 2021 | $356,000 | – | 7,380 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |